Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.41 USD | +2.92% | -6.62% | -51.88% |
May. 09 | Carisma Therapeutics, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
May. 02 | Carisma Therapeutics Appoints Dr. Eugene P. Kennedy as Chief Medical Officer | CI |
Evolution of the average Target Price on Carisma Therapeutics, Inc.
Price target over the last 5 years
History of analyst recommendation changes
Analysts' Consensus
Consensus detail
Consensus revision (last 18 months)
Analysts covering Carisma Therapeutics, Inc.
BTIG | |
HC Wainwright | |
Capital One Securities | |
Evercore ISI | |
Baird | |
Canaccord Genuity | |
Jefferies & Co. |
EPS Revisions
- Stock Market
- Equities
- CARM Stock
- Consensus Carisma Therapeutics, Inc.